Related references
Note: Only part of the references are listed.Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: Comparison with Memantine
Fatemeh Hemmati et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Drugs in Development for Relapsing Multiple Sclerosis
Rehiana Ali et al.
DRUGS (2013)
Fingolimod protects cultured cortical neurons against excitotoxic death
Luisa Di Menna et al.
PHARMACOLOGICAL RESEARCH (2013)
Polyglutamine domain flexibility mediates the proximity between flanking sequences in huntingtin
Nicholas Stephane Caron et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A novel target for Huntington's disease: ERK at the crossroads of signaling
Laszlo Bodai et al.
BIOESSAYS (2012)
Protein aggregates in Huntington's disease
Montserrat Arrasate et al.
EXPERIMENTAL NEUROLOGY (2012)
Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis
Kenji Chiba et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Serine Phosphorylation Suppresses Huntingtin Amyloid Accumulation by Altering Protein Aggregation Properties
Rakesh Mishra et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Early tolerability and safety of fingolimod in clinical practice
Daniel Ontaneda et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
FTY720, sphingosine 1-phosphate receptor modulator, selectively radioprotects hippocampal neural stem cells
Alexander M. Stessin et al.
NEUROSCIENCE LETTERS (2012)
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome
Ruben Deogracias et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice
Alba Di Pardo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model
Hye Jung Kim et al.
FASEB JOURNAL (2011)
Myelin-associated glycoprotein protects neurons from excitotoxicity
Pablo H. H. Lopez et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Peroxisome-Proliferator-Activated Receptor Gamma Coactivator 1 α Contributes to Dysmyelination in Experimental Models of Huntington's Disease
Zhongmin Xiang et al.
JOURNAL OF NEUROSCIENCE (2011)
Levels of BDNF Impact Oligodendrocyte Lineage Cells following a Cuprizone Lesion
Melissa W. VonDran et al.
JOURNAL OF NEUROSCIENCE (2011)
Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction
Albert Giralt et al.
MOLECULAR NEURODEGENERATION (2011)
Kinase inhibitors modulate huntingtin cell localization and toxicity
Randy Singh Atwal et al.
NATURE CHEMICAL BIOLOGY (2011)
Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease
Jeffrey B. Carroll et al.
NEUROBIOLOGY OF DISEASE (2011)
Mutant Huntingtin Alters Cell Fate in Response to Microtubule Depolymerization via the GEF-H1-RhoA-ERK Pathway
Hemant Varma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
BDNF Overexpression in the Forebrain Rescues Huntington's Disease Phenotypes in YAC128 Mice
Yuxiang Xie et al.
JOURNAL OF NEUROSCIENCE (2010)
Impaired Ganglioside Metabolism in Huntington's Disease and Neuroprotective Role of GM1
Vittorio Maglione et al.
JOURNAL OF NEUROSCIENCE (2010)
Activation of Sphingosine-1-Phosphate 1 Receptor in the Proximal Tubule Protects Against Ischemia-Reperfusion Injury
Amandeep Bajwa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Ceramide Synthesis Is Modulated by the Sphingosine Analog FTY720 via a Mixture of Uncompetitive and Noncompetitive Inhibition in an Acyl-CoA Chain Length-dependent Manner
Sujoy Lahiri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome
Leslie Michels Thompson et al.
JOURNAL OF CELL BIOLOGY (2009)
Axonal Protective Effects of the Myelin-Associated Glycoprotein
Thien Nguyen et al.
JOURNAL OF NEUROSCIENCE (2009)
Alterations in Cortical Excitation and Inhibition in Genetic Mouse Models of Huntington's Disease
Damian M. Cummings et al.
JOURNAL OF NEUROSCIENCE (2009)
Serines 13 and 16 Are Critical Determinants of Full-Length Human Mutant Huntingtin Induced Disease Pathogenesis in HD Mice
Xiaofeng Gu et al.
NEURON (2009)
Cross-talk between PDGF and S1P signalling elucidates the inhibitory effect and potential antifibrotic action of the immunomodulator FTY720 in activated HSC-cultures
Anna Maria Brunati et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Central nervous system-directed effects of FTY720 (fingolimod)
Veronique E. Miron et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis
Kumlesh K. Dev et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: Consequences for mode of action in multiple sclerosis
Carolyn A. Foster et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors
Rochelle P. Coelho et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology
Volker Brinkmann
PHARMACOLOGY & THERAPEUTICS (2007)
Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors
Maribel Osinde et al.
NEUROPHARMACOLOGY (2007)
AKT and CDK5/p35 mediate brain-derived neurotrophic factor induction of DARPP-32 in medium size spiny neurons in vitro
Alexey Bogush et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The immunosuppressant drug FTY720 inhibits cytosohc phospholipase A2 independently of sphingosine-1-phosphate receptors
Shawn G. Payne et al.
BLOOD (2007)
Huntington's disease:: from huntingtin function and dysfunction to therapeutic strategies
M. Borrell-Pages et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses
Guy M. L. Meno-Tetang et al.
DRUG METABOLISM AND DISPOSITION (2006)
Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity
BL Apostol et al.
HUMAN MOLECULAR GENETICS (2006)
Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease
CL Benn et al.
HUMAN MOLECULAR GENETICS (2005)
Akt is altered in an animal model of Huntington's disease and in patients
E Colin et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Increased GABAergic function in mouse models of Huntington's disease:: Reversal by BDNF
C Cepeda et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules
LR Gauthier et al.
CELL (2004)
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
M Arrasate et al.
NATURE (2004)
Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases
A Billich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders
I Sánchez et al.
NATURE (2003)
Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases
F Aboul-Enein et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
The immune modulator FTY720 targets sphingosine 1-phosphate receptors
V Brinkmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves huntingtin phosphorylation by Akt
S Humbert et al.
DEVELOPMENTAL CELL (2002)
Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease
C Zuccato et al.
SCIENCE (2001)
Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice
JA Bibb et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
